sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo

BACKGROUND: In a previous analysis using a lung cancer cell line model, we have found that therapies directed against secreted clusterin (sCLU) and its downstream signaling targets pAkt and pERK1/2 may have the potential to enhance the efficacy of cisplatin (DDP)-based chemotherapy in vitro. Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Guoliang, Cai, Hengjuan, Gao, Lizhen, Wang, Mei, Wang, Haixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358856/
https://www.ncbi.nlm.nih.gov/pubmed/25884382
http://dx.doi.org/10.1186/s12957-015-0501-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358856/
https://www.ncbi.nlm.nih.gov/pubmed/25884382
http://dx.doi.org/10.1186/s12957-015-0501-1

Ejemplares similares